Nuplura PH provides single dose protection against pasteurella pneumonia (shipping fever) caused by Mannheimia haemolytica in cattle 3 months of age and older. A single dose demonstrated protective immunity as early as 10 days after administration. Recombinant leukotoxoid technology to provide a strong immune response. Give 2 ml SQ. A booster can be given prior to periods of stress or elevated risk of exposure. Safety has been demonstrated in calves 28 days of age and older.
Recombinant Leukotoxoid Technology — Nuplura PH is the first and only cattle vaccine developed in the U.S. market using a combination of outer membrane protein (OMP) and recombinant leukotoxoid technology. Nuplura PH contains consistent levels of leukotoxoid in every dose to provide a strong immune response.
Purified Antigen — Nuplura PH is not a simple, inactivated whole-cell product like most other bacterins. It contains outer membrane proteins that have been extracted and purified through a proprietary process. The result is a reduction of cellular debris, which allows the immune system to focus entirely on critical bacterial components.
Fast Onset of Immunity — Nuplura PH is the only Mannheimia haemolytica vaccine demonstrated to deliver immunity as soon as 10 days.
Minimal Reactivity — The unique formulation of Nuplura PH is gentle on calves. Administered as directed, there should be no effect on the meat or the carcass at slaughter due to injection site reactions.